ArticleScientific reports2026
Simultaneously improve mechanical properties and osteogenic properties of biodegradable Zn alloys by refining grain sizes to sub-micrometers.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Precise modulation of degradation behavior is vital for the biomedical use of biodegradable zinc-based alloys. Variations in electrochemical potential between the Zn matrix and secondary phases markedly influence both the mechanical performance and corrosion characteristics of these alloys. In this work, a zinc alloy with an ultrafine-grained (UFG) structure was fabricated through a two-step rolling process, refining the grain size from 17.28 μm to 0.41 μm (a percentage reduction of 98%). The resulting material exhibited outstanding mechanical strength and ductility, achieving values of 383 MPa in tensile strength and 114% in elongation at ambient temperature. Microstructural analysis revealed uniformly refined grains accompanied by CuZn
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.